Skip to main content
TransThera Sciences (Nanjing), Inc. logo

TransThera Sciences (Nanjing), Inc. — Investor Relations & Filings

Ticker · 2617 ISIN · CNE100006T02 HKEX Manufacturing
Open in API
Filings indexed 91 across all filing types
Latest filing 2026-06-18 Governance Information
Country HK Hong Kong
Listing HKEX 2617

About TransThera Sciences (Nanjing), Inc.

https://www.transthera.com

TransThera Sciences (Nanjing), Inc. is a clinical-stage, R&D-driven biopharmaceutical company focused on the discovery, development, and commercialization of innovative small molecule therapies. Established in 2014, the company employs a clinical demand-oriented approach to address diseases with significant unmet medical needs. TransThera's pipeline is dedicated to generating first-in-class, best-in-class, and highly differentiated treatments, primarily targeting therapeutic areas such as oncology, inflammatory diseases, and cardiovascular conditions.

Recent filings

Filing Released Lang Actions
Terms of Reference of the Strategy Committee of the Board of Directors
Governance Information Classification · 95% confidence The document is titled 'Terms of Reference of the Strategy Committee of the Board of Directors' and details the establishment, composition, duties, meeting procedures, and governance structure of a Strategy Committee within the Board of Directors. It references regulatory laws and internal company governance rules but contains no financial data, results, or outcomes. It is not an annual or interim report, audit report, earnings release, or similar financial disclosure. Nor is this a regulatory filing about a specific event like a director change or share transaction. The document is a governance-related document focusing on the internal structure and operating procedures of a board committee, detailing how the committee functions and its responsibilities within corporate governance. Therefore, it fits best in a governance-related filing category that deals with board structure and practices.
2026-06-18 English
Terms of Reference of the Remuneration and Appraisal Committee of the Board of Directors
Remuneration Information Classification · 90% confidence The document text is a detailed "Terms of Reference" for the Remuneration and Appraisal Committee of the Board of Directors of TransThera Sciences (Nanjing), Inc. It specifies the duties, composition, procedures, responsibilities, and governance related to remuneration and appraisal for the directors and senior management. It references corporate governance codes and Listing Rules but does not contain financial statements or actual remuneration figures. The document is a governance-related disclosure, focusing on the committee's formation, responsibilities, and procedures concerning remuneration policies rather than individual remuneration details or compensation data. Therefore, it is not a compensation report per se (such as DEF 14A) which typically contains executive compensation tables and disclosure. Instead, it fits best under Remuneration Information filings that explain the policies and committee terms for executive and director compensation management.
2026-06-18 English
Terms of Reference of the Nomination Committee of the Board of Directors
Governance Information Classification · 95% confidence The document is titled 'Terms of Reference of the Nomination Committee of the Board of Directors' for TransThera Sciences (Nanjing), Inc. and contains detailed provisions about the role, composition, duties, authorities, and procedural rules of the Nomination Committee. It discusses governance matters such as the appointment, evaluation, and selection criteria for directors and senior management. There are extensive references to regulatory frameworks related to board governance and committee function but no financial data or results. It focuses on governance structure rather than report publication, financial performance, or shareholder decisions. According to the definitions, such a document falls under Governance Information (Code: CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length (>15,000 chars) supports this as a substantive governance report rather than a brief announcement or statement.
2026-06-18 English
Terms of Reference of the Audit Committee of the Board of Directors
Audit Report / Information Classification · 80% confidence The document is titled 'Terms of Reference of the Audit Committee of the Board of Directors' for TransThera Sciences (Nanjing), Inc. It lays out the composition, duties, and authorities of the Audit Committee with a focus on financial oversight, internal and external audit supervision, and internal control. This is a corporate governance and audit-related policy document rather than a financial report or audit report itself. No actual financial statements, audit results, or certifications are included, only guidelines and roles for the audit committee. It does not describe appointment changes in directors or senior management, earnings data, voting results, or all other report types. Therefore, it best fits into 'Audit Report / Information (AR)' as it describes the framework and responsibilities regarding audit oversight rather than presenting actual audit findings or full annual reports, but since it is a detailed document about audit committee functions and does not contain audit results, it classifies as AR with moderate confidence. FY 2024
2026-06-18 English
Articles of Association
Governance Information Classification · 95% confidence The document is the 'Articles of Association' for a company, TransThera Sciences (Nanjing), Inc. It contains detailed corporate governance information including structure, share issuance, board of directors, shareholders' rights, and other company rules. It is not a financial performance report, earnings report, nor a regulatory announcement. It matches the description of a detailed governance document specifying internal rules and company governance, which aligns with the 'Governance Information' (CGR) category. The length and content confirm it is a substantive document, not just an announcement or summary.
2026-06-18 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 100% confidence The document lists the names of the board of directors, their titles, and committee memberships within TransThera Sciences (Nanjing), Inc. It focuses solely on governance-related information about board composition and committee roles. There are no financial statements, audit opinions, voting results, or regulatory filings discussed. This matches the category describing announcements or disclosures about changes or information related to the company's board or senior management. Thus, the most fitting classification is 'Board/Management Information (MANG)'. The document is short and specific to board information, providing high confidence in this classification.
2026-06-18 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.